The U.S. Food and Drug Administration has accepted Kowa’s application for a new glaucoma eye drop. The agency has not yet disclosed a target review date.
Further details about the drug candidate were not immediately available.
FDA accepts Kowa’s glaucoma eye drop application
The U.S. regulator has formally accepted Kowa’s application for a new glaucoma treatment.
SL
Sophie Laurent · FX & Rates Desk · 27 Aug 2026 · 15:24 · 1 min read
This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
SL
Written by
Sophie Laurent
FX & Rates Desk
Sophie covers currency markets and central bank policy across Europe, with a focus on how rate decisions ripple through FX pairs. She has been tracking the ECB's policy path since the start of the current easing cycle.
More from Sophie Laurent →
